Additional file 1 of FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study

Additional file 1: Additional fig. 1. (a) Haemoglobin (Hb) level at baseline and worse point during the FOLFOX treatment. White and black boxes represent Hb levels at baseline and worse point, respectively. Concomitant grades 1 and 2 anaemia at baseline was observed in 12 and 12 patients, respectively. (b) Change in Haemoglobin (Hb) level from baseline to worse point during the FOLFOX treatment. Most patients showed a decrease in Hb within 2.0 g/dL, except for three patients.补充材料1：补充图1。(a) 基线期及FOLFOX治疗期间最差时点的血红蛋白（Haemoglobin，Hb）水平。白色与黑色箱形图分别代表基线期与最差时点的Hb水平。基线期合并1级和2级贫血的患者分别为12例与12例。(b) FOLFOX治疗期间血红蛋白（Hb）水平从基线至最差时点的变化情况。除3例患者外，多数患者的Hb下降幅度均在2.0 g/dL以内。